Use of extracorporeal membrane oxygenation (ECMO) in children receiving haematopoietic
cell transplantation (HCT) and immune effector cell therapy is controversial and evidence …

Background: Bacterial and fungal infections are common and often contribute to death in
patients undergoing extracorporeal membrane oxygenation (ECMO). Drug disposition is …

Extracorporeal life support (ECLS), including extracorporeal membrane oxygenation
(ECMO) and continuous renal replacement therapy (CRRT), is a lifesaving therapy for …

OBJECTIVES: To identify and prioritize research questions for anticoagulation and
hemostasis management of neonates and children supported with extracorporeal …

Background: Cefepime is a first-line therapy for Gram-negative infections in children on
extracorporeal membrane oxygenation. Cefepime pharmacokinetics (PK) in children on …

Background Dexmedetomidine is a sedative and analgesic increasingly used in children
supported with extracorporeal membrane oxygenation (ECMO). No data is available to …

The objective of this study was to describe the pharmacokinetics (PK) of intravenous
phenobarbital in neonates and infants on extracorporeal membrane oxygenation (ECMO) …

Objectives: To develop a population pharmacokinetic model for IV phenobarbital in
neonates following cardiac surgery and perform simulations to identify optimal dosing …

This study aimed to identify drug administration patterns in patients of all ages supported
with extracorporeal membrane oxygenation (ECMO) across multiple institutions and …